Skip to main content

Table 1 Patient Demographics and Clinical Characteristics

From: Thymidine Phosphorylase/β-tubulin III expressions predict the response in Chinese advanced gastric cancer patients receiving first-line capecitabine plus paclitaxel

Characteristic

Cohort 1 (n = 33)

Cohort 2 (n = 18)

Total (n = 51)

 

No. of Patients

%

No. of Patients

%

No. of Patients

%

Sex

      

   Male

20

60.6

14

77.8

34

66.7

   female

13

39.4

4

22.2

17

33.3

Age, years

      

   Median

57

57

57

   Range

27-74

42-75

27-75

KPS

      

   90-100

23

69.7

14

77.8

37

72.5

   70-80

10

30.3

4

22.2

14

27.5

Sites of metastatic disease

      

   Liver

12

36.4

6

33.3

18

35.3

   Lung

1

3.0

4

22.2

5

9.8

   Lymph nodes

33

100

17

94.4

50

98.0

   Peritoneum

6

18.2

3

16.7

9

17.6

   Others*

8

24.2

4

22.2

12

23.5

Histological differentiation #

      

   Poor

25

75.8

11

61.1

36

70.6

   Good

8

24.2

7

38.9

15

29.4

  1. NOTE: *Including ovary, adrenal glands, subcutaneous of abdominal wall, pelvic cavity, bone and thoracic cavity. #Poor, including poorly differentiated adenocarcinoma, signet ring cell carcinoma and mucinous adenocarcinoma; Good, including moderate-well differentiated adenocarcinoma. KPS, Kamofsky performance status.